The Association Between Circulating Inflammatory Markers and the Progression of Alzheimer Disease in Norwegian Memory Clinic Patients With Mild Cognitive Impairment or Dementia
Authors:
- 13 August 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Alzheimer Disease & Associated Disorders
- Vol. 34 (1) , 47-53
Abstract
Objective: Neuroinflammation may play an important role in the pathogenesis and progression of Alzheimer disease (AD). The aim of the present study was to detect whether increased inflammatory activity at baseline could predict cognitive and functional decline in patients with amnestic mild cognitive impairment (aMCI) or AD dementia after 2 years. Methods: Serum samples from 242 memory clinic patients with an aMCI (n=88) or AD dementia (n=154) were analyzed for C-reactive protein and for 14 other inflammatory markers [interleukin (IL)-1β, interleukin-1 receptor antagonist, IL-6, IL-10, IL-12p40, IL-17a, IL-18, IL-22, IL-33, tumor necrosis factor, cluster of differentiation 40 ligand, interferon-γ, chemokine ligand (CCL) 2, and CCL4] by bead-based multiplex immunoassay. Disease progression was measured by the annual increase in the Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) and annual decrease in the score on the Mini-Mental State Examination (MMSE). Results: No association between increased levels of the inflammatory markers and change on the CDR-SB or MMSE score was found, but there was a significant difference in baseline IL-6 and interleukin-1 receptor antagonist levels between aMCI and AD dementia groups. Conclusion: Increased levels of inflammatory markers were not associated with faster progression as measured by the annual change on the CDR-SB or MMSE score.Keywords
This publication has 37 references indexed in Scilit:
- Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegenerationSeminars in Immunopathology, 2013
- Outcomes of Mild Cognitive Impairment by DefinitionArchives of Neurology, 2011
- Cerebral Amyloid Angiopathy: A Systematic ReviewJournal of Clinical Neurology, 2011
- Systemic inflammation and disease progression in Alzheimer diseaseNeurology, 2009
- CCL2 Accelerates Microglia-Mediated Aβ Oligomer Formation and Progression of Neurocognitive DysfunctionPLOS ONE, 2009
- Prerequisites for cytokine measurements in clinical trials with multiplex immunoassaysBMC Immunology, 2009
- Staging Dementia Using Clinical Dementia Rating Scale Sum of Boxes ScoresArchives of Neurology, 2008
- Dementia Diagnosis DisclosureAlzheimer Disease & Associated Disorders, 2007
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- A New Clinical Scale for the Staging of DementiaThe British Journal of Psychiatry, 1982